Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
Clinical trial NCT04076579 · COMPLETED
Trial details
- NCT number
- NCT04076579
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-17
- Primary completion
- 2023-01-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.